Back to list

With 10 million people already vaccinated in the UK, Matt Hancock (UK Health secretary) praised a study which suggests the Oxford-AstraZeneca vaccine may reduce the coronavirus transmission rates. 


Although the results have not been published formally, Matt Hancock stated that he is hopeful that "the vaccine could be the way out of this pandemic". Apart from being effective in reducing the transmission, studies indicate that a single dose of vaccine has 76% effectiveness against the virus for three months which increases to 82% upon the second dosage. 


The UK has taken a separate route compared to many other countries in the world. It has prioritised giving the first dosage to as many people as possible to ensure some protection against the virus. They have delayed the second jab by 12 weeks. Professor Andrew Pollard, chief investigator of the Oxford vaccine trial said, "reassures us that people are protected from 22 days after a single dose of the vaccine". 


Mr Hancock also assured the citizens that scientists are closely observing the cases of people over 65. He expressed "high degree of confidence" in the vaccine being useful for people of all ages. Healthcare authorities have also confirmed that the vaccine is effective on the different mutants of the virus. Dr Pollard concluded by saying, "we will have built up enough immunity to prevent the other severe disease that we've been seeing over the last year." 


The UK has seen over 50% decrease in the number of coronavirus cases in February compared to the previous month. Indian students planning to study in the UK are very encouraged by this positive news. If you are planning to study in the UK, we advise you to apply as soon as possible. Please contact us and our expert counsellors will be able to advise you and support you through the application process.  

The source of this article was from BBC News 

With 28 years of professional experience,
UKEAS provides whole range of counselling service for your dream blueprint.
By continuing to use this site, you agree to the use of cookies. Click here for our full privacy policy